1. Chimeric Antigen Receptor Therapy;June;N. Engl. J. Med.,2018
2. FDA approves first BCMA-targeted CAR-T cell therapy;Mullard;Nat. Rev. Drug Discov.,2021
3. FDA approves second BCMA-targeted CAR-T cell therapy;Mullard;Nat. Rev. Drug Discov.,2022
4. FDA approves first CAR T therapy;Mullard;Nat. Rev. Drug Discov.,2017
5. FDA Approves Second CAR T-cell Therapy;Cancer Discov.,2018